16 -10 (84) 2025 - Sh.M. Khamidova - MODERN STRATEGIES FOR MEDICAL COMPORTANCE OF PREGNANCY IN PATIENTS WITH DISTRIBUTED SCLEROSIS

MODERN STRATEGIES FOR MEDICAL COMPORTANCE OF PREGNANCY IN PATIENTS WITH DISTRIBUTED SCLEROSIS

Sh.M. Khamidova - Samarkand State Medical University

Resume

Multiple sclerosis (MS) is one of the most common chronic demyelinating diseases of the central nervous system, affecting primarily young people. Management of pregnancy in patients with RS is of particular medical and social importance, as the disease manifests itself during the most active reproductive period of a woman's life - at the age of 20-40. For a long time, multiple sclerosis pregnancy was considered unwanted and potentially dangerous for both mother and fetus. These ideas were based on assumptions about the negative impact of the gestational process on the course of the demyelinating disease and the high risk of pathology transmission to offspring. However, the results of major prospective studies in the last two decades have fundamentally changed the understanding of the relationship between RS and pregnancy.

Keywords: multiple sclerosis, pregnancy, immunomodulatory therapy, exacerbation, postpartum period.

First page

86

Last page

90

For citation:Sh.M. Khamidova - MODERN STRATEGIES FOR MEDICAL COMPORTANCE OF PREGNANCY IN PATIENTS WITH DISTRIBUTED SCLEROSIS//New Day in Medicine 10(84)2025 86-90 https://newdayworldmedicine.com/en/new_day_medicine/10-84-2025

List of References

  1. Алифирова В.М., Бисага Г.Н., Трошина Е.М. Рассеянный склероз и беременность: современные аспекты ведения пациенток // Журнал неврологии и психиатрии им. С.С. Корсакова. 2020;120(4):76-84.
  2. Бойко А.Н., Гусев Е.И., Демина Т.Л. и др. Рассеянный склероз: диагностика, лечение, специалисты. Клинические рекомендации. / М.: Изд-во «Реал Тайм», 2021; 180 стр.
  3. Завалишин И.А., Головкин В.И. Рассеянный склероз. Избранные вопросы теории и практики. / М.: Медицина, 2019; 640 стр.
  4. Confavreux C., Hutchinson M., Hours M.M., Cortinovis-Tourniaire P., Moreau T.; Pregnancy in Multiple Sclerosis Group. Rate of pregnancy-related relapse in multiple sclerosis // N. Engl. J. Med. 1998;339(5):285-291.
  5. Dobson R., Dassan P., Roberts M. et al. UK consensus on pregnancy in multiple sclerosis: 'Association of British Neurologists' guidelines // Pract. Neurol. 2019;19(2):106-114.
  6. Hellwig K., Haghikia A., Rockhoff M., Gold R. Multiple sclerosis and pregnancy: experience from a nationwide database in Germany // Ther. Adv. Neurol. Disord. 2012;5(5):247-253.
  7. Langer-Gould A., Huang S.M., Gupta R. et al. Exclusive breastfeeding and the risk of postpartum relapses in women with multiple sclerosis // Arch. Neurol. 2009;66(8):958-963.
  8. Lu E., Wang B.W., Guimond C., Synnes A. et al. Disease-modifying drugs for multiple sclerosis in pregnancy: a systematic review // Neurology. 2012;79(11):1130-1135.
  9. Portaccio E., Moiola L., Martinelli V. et al. Pregnancy decision-making in women with multiple sclerosis treated with natalizumab: II: Maternal risks // Neurology. 2018;90(10):832-839.
  10. Vukusic S., Hutchinson M., Hours M. et al. Pregnancy and multiple sclerosis (the PRIMS study): clinical predictors of post-partum relapse // Brain. 2004;127(6):1353-1360.
  11. Wendel E.M., Bertolini A., Midaglia L. et al. Multiple sclerosis: The impact of pregnancy and childbirth // J. Autoimmun. 2020;107:102-374.
  12. Zecca C., Riccitelli G.C., Disanto G. et al. Treatment of multiple sclerosis during pregnancy and breastfeeding // Expert. Opin. Drug. Saf. 2020;19(6):623-633.

    file

    download